Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma by Ingrid Quist-Lokken, Mira Tilseth, Clara Andersson-Rusch, Md Abu Hanif, Michael Walz, Johanna Fredrikke Nordstrand Moen, Megan Anne Vik, Tobias Schmidt Slordahl, Anders Sundan, Felix Hausch, Toril Holien

Get full text

Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma—A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone by Tobias S. Slørdahl, Frida Bugge Askeland, Margrete Sofie Sætre Hanssen, Håkon Hov, Stine Marie Sundt‐Hansen, Sofia Lindahl, Nils Tore Vethe, Henrik Hjorth‐Hansen, Mona H. Fenstad, Anders Waage, Øyvind Hjertner, Fredrik Schjesvold, Anders Sundan

Get full text

Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade by Torstein Baade Rø, Rui Yang, Zachary Cooper, Richard Woessner, Samah Elsaadi, Kristine Misund, Pegah Abdollahi, Esten Nymoen Vandsemb, Siv Helen Moen, Anna Kusnierczyk, Geir Slupphaug, Therese Standal, Anders Waage, Tobias S Slørdahl, Even Rustad, Anders Sundan, Carl Hay, Alwin G Schuller, Alexandra Borodovsky, Eline Menu, Magne Børset, Anne Marit Sponaas

Get full text